SLC5A2 and gastrointestinal disease: Our MR results showed that SGLT2 inhibitors, DDP-4 inhibitors, Insulin and its analogs, Thiazolidinedione, and other drugs did not have significant effects on gastrointestinal diseases and were not further analyzed.